Diversity in Oncology fosters courageous conversations about strategies for the delivery of equitable high quality cancer care for all including clinical trials, so that this cross-stakeholder, cross-cultural initiative can take action to make the clinical trial enterprise more inclusive and responsive to populations that are currently underrepresented.
Who Should Attend
- Local and national community organizations that focus on health equity
- Patients and caregivers
- Healthcare providers
- Clinical trial teams and principal investigators
- Schools of public health
- Anyone interested in discussing health equity in clinical trials